| Also known as | ANXA1 |
| Other names | Annexin A1, Annexin I, Annexin-1, Calpactin II, Calpactin-2, Chromobindin-9, Lipocortin I, Phospholipase A2 inhibitory protein, annexin A1, annexin A1, annexin I (lipocortin I), annexin-1, calpactin II, calpactin-2, chromobindin-9, lipocortin I, p35, p35, phospholipase A2 inhibitory protein, annexin A1 |
| Category | Antibodies |
| Subcategory | Mnoclonal antibodies |
| Gene name | ANXA1 |
| Gene name synonims | N/A |
| Other gene names | ANX1, ANX1, ANXA1, LPC1, LPC1, ANXA1 |
| Clonality | Monoclonal |
| Immunoglobulin isotype | IgG1 |
| Clone | 3A8 |
| Host organism | Mouse (Mus musculus) |
| Species reactivity | Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby, Human (Homo sapiens) |
| Specificity and cross-reactivity | Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited, This particular antibody might cross react with speacies outside of the listed ones, N/A |
| Purification method | ANXA1 antibody was purified by affinity chromatography |
| Form/Appearance | 50% glycerol and 0, containing 1% BSA, pH 7, 02% sodium azide, 3, Supplied in PBS buffer |
| Concentration | 500 ug-1 miligram per 1 mililiter |
| Storage and shipping | Cycles of freezing and defrosting may denaturate the polypeptide chains of the antibodies, Long term storage should be done after aliquoting and at -20°, thus reducing their activity, C, For shorter periods of time keep the antibody at +4 degrees Celsius |
| Tested applications: | Immunohistochemistry (IHC), Western Blot (WB), Immunofluorescence (IF) |
| French translation | anticorps |
| Gene target | ANXA1 |
| Short name | ANXA1 antibody |
| Alternative name | annexin A1 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | ANX1 and LPC1, ANXA1 and IDBG-71054 and ENSG00000135046 and 301, Anxa1 and IDBG-151723 and ENSMUSG00000024659 and 16952, BT, bridging, bridging and also this GO :0033676: double-stranded DNA-dependent ATPase activity and also this GO :0036310: annealing helicase activity and also this GO :0042803: protein homodimerization activity and also this GO :0048306: calcium-dependent protein binding, bridging and molecular function this GO :0030850 and prostate gland development and biological process this GO :0031018 and endocrine pancreas development and biological process this GO :0031340 and positive regulation of vesicle fusion and biological process this GO :0031394 and positive regulation of prostaglandin biosynthetic process and biological process this GO :0031960 and response to corticosteroid and biological process this GO :0031966 and mitochondrial membrane and cellular component this GO :0032355 and response to estradiol and biological process this GO :0032508 and DNA duplex unwinding and biological process this GO :0033031 and positive regulation of neutrophil apoptotic process and biological process this GO :0033676 and double-stranded DNA-dependent ATPase activity and molecular function this GO :0036292 and DNA rewinding and biological process this GO :0036310 and annealing helicase activity and molecular function this GO :0042063 and gliogenesis and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042383 and sarcolemma and cellular component this GO :0042493 and response to drug and biological process this GO :0042629 and mast cell granule and cellular component this GO :0042803 and protein homodimerization activity and molecular function this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043234 and protein complex and cellular component this GO :0043434 and response to peptide hormone and biological process this GO :0045087 and innate immune response and biological process this GO :0046632 and alpha-beta T cell differentiation and biological process this GO :0048306 and calcium-dependent protein binding and molecular function this GO :0050482 and arachidonic acid secretion and biological process this GO :0050709 and negative regulation of protein secretion and biological process this GO :0051384 and response to glucocorticoid and biological process this GO :0060206 and estrous cycle phase and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070301 and cellular response to hydrogen peroxide and biological process this GO :0070365 and hepatocyte differentiation and biological process this GO :0070459 and prolactin secretion and biological process this GO :0070555 and response to interleukin-1 and biological process this GO :0071385 and cellular response to glucocorticoid stimulus and biological process this GO :0097350 and neutrophil clearance and biological process this GO :1900087 and positive regulation of G1/S transition of mitotic cell cycle and biological process this GO :1900138 and negative regulation of phospholipase A2 activity and biological process this GO :2000483 and negative regulation of interleukin-8 secretion and biological process, nuclei, protein binding, this GO :0000733 and DNA strand renaturation and biological process this GO :0001533 and cornified envelope and cellular component this GO :0001780 and neutrophil homeostasis and biological process this GO :0003697 and single-stranded DNA binding and molecular function this GO :0003727 and single-stranded RNA binding and molecular function this GO :0004386 and helicase activity and molecular function this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005198 and structural molecule activity and molecular function this GO :0005509 and calcium ion binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005544 and calcium-dependent phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005929 and cilium and cellular component this GO :0006200 and ATP catabolic process and biological process this GO :0006928 and cellular component movement and biological process this GO :0006954 and inflammatory response and biological process this GO :0007165 and signal transduction and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0009725 and response to hormone and biological process this GO :0009986 and cell surface and cellular component this GO :0010165 and response to X-ray and biological process this GO :0014070 and response to organic cyclic compound and biological process this GO :0016323 and basolateral plasma membrane and cellular component this GO :0018149 and peptide cross-linking and biological process this GO :0019834 and phospholipase A2 inhibitor activity and molecular function this GO :0030073 and insulin secretion and biological process this GO :0030216 and keratinocyte differentiation and biological process this GO :0030674 and protein binding, this GO :0003697: single-stranded DNA binding, this GO :0003697: single-stranded DNA binding and also this GO :0003727: single-stranded RNA binding and also this GO :0004386: helicase activity and also this GO :0004859: phospholipase inhibitor activity and also this GO :0005102: receptor binding and also this GO :0005198: structural molecule activity and also this GO :0005509: calcium ion binding and also this GO :0005515: protein binding and also this GO :0005543: phospholipid binding and also this GO :0005544: calcium-dependent phospholipid binding and also this GO :0019834: phospholipase A2 inhibitor activity and also this GO :0030674: protein binding, this GO :0003727: single-stranded RNA binding, this GO :0004386: helicase activity, this GO :0004859: phospholipase inhibitor activity, this GO :0005102: receptor binding, this GO :0005198: structural molecule activity, this GO :0005509: calcium ion binding, this GO :0005515: protein binding, this GO :0005543: phospholipid binding, this GO :0005544: calcium-dependent phospholipid binding, this GO :0019834: phospholipase A2 inhibitor activity, this GO :0030674: protein binding, this GO :0033676: double-stranded DNA-dependent ATPase activity, this GO :0036310: annealing helicase activity, this GO :0042803: protein homodimerization activity, this GO :0048306: calcium-dependent protein binding, 70631 and IDBG-632306 and ENSBTAG00000015978 and 327662, annexin A1 |
| Identity | 533 |
| Gene | ANXA1 |
| Long gene name | annexin A1 |
| Synonyms gene | ANX1 LPC1 |
| Locus | 9q21, 13 |
| Discovery year | 2001-06-22 |
| GenBank acession | X05908 |
| Entrez gene record | 301 |
| Pubmed identfication | 2936963 |
| RefSeq identity | NM_000700 |
| Classification | Endogenous ligands Annexins |
| Havana BLAST/BLAT | OTTHUMG00000020016 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue